Higher S-adenosylhomocysteine and lower ratio of S-adenosylmethionine to S-adenosylhomocysteine were more closely associated with increased risk of subclinical atherosclerosis than homocysteine
- PMID: 36034911
- PMCID: PMC9399787
- DOI: 10.3389/fnut.2022.918698
Higher S-adenosylhomocysteine and lower ratio of S-adenosylmethionine to S-adenosylhomocysteine were more closely associated with increased risk of subclinical atherosclerosis than homocysteine
Abstract
Aim: To examine the relationship of C1 metabolites of the methionine cycle with the risk of subclinical atherosclerosis (SA) in the Chinese population.
Methods: A total of 2,991 participants aged 45-75 years old were included for data analyses based on the baseline data of the Guangzhou Nutrition and Health Cohort. Three core serum methionine metabolites including serum S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), and homocysteine (Hcy) were measured by UPLC-MS/MS. SA was determined by B-mode ultrasound measured carotid intima-media thickness (CIMT) at the common artery and bifurcation segments. Multivariable logistic and linear regression models were performed to estimate the associations of C1 metabolites of the methionine cycle with SA risk or CIMT.
Results: After controlling for potential cofounders and other C1 metabolites, in comparison with the lowest quartile, participants in the highest quartile had lower risk of SA by 27.6% (OR = 0.724; 95% CI:0.563-0.93, P trend = 0.007) for SAM and 32.2% (OR = 0.678; 95% CI:0.538-0.855, P trend < 0.001) for SAM/SAH, while increased SA risk by 27.9% (OR = 1.279; 95% CI: 1.065-1.535, P trend < 0.001) for SAH. No significant association was observed for Hcy with SA after further adjustment of SAH and SAM. The results of multivariable linear regression showed similar findings. The highest two standardized coefficients were observed for SAH (β = 0.104 for CCA and 0.121 for BIF, P< 0.001) and SAM/SAH (β = -0.071 for CCA and -0.084 for BIF, P< 0.001). Subgroup analyses suggested more evident associations of SAH with SA were observed in participants of higher cardiovascular risk profiles.
Conclusion: Our cross-sectional data showed higher serum SAH, but lower SAM/SAH were independently associated with increased risk of SA among the Chinese middle-aged and elderly population.
Keywords: S-adenosylhomocysteine; S-adenosylmethionine; homocysteine; intima-media thickness; subclinical atherosclerosis.
Copyright © 2022 Xiao, You, Chen, Tang, Chen, Liu, Liu and Ling.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Association of serum methionine metabolites with non-alcoholic fatty liver disease: a cross-sectional study.Nutr Metab (Lond). 2022 Mar 18;19(1):21. doi: 10.1186/s12986-022-00647-7. Nutr Metab (Lond). 2022. PMID: 35303918 Free PMC article.
-
Association of Homocysteine, S-Adenosylhomocysteine and S-Adenosylmethionine with Cardiovascular Events in Chronic Kidney Disease.Nutrients. 2025 Feb 10;17(4):626. doi: 10.3390/nu17040626. Nutrients. 2025. PMID: 40004955 Free PMC article.
-
Serum S-adenosylhomocysteine, rather than homocysteine, is associated with hepatocellular carcinoma survival: a prospective cohort study.Am J Clin Nutr. 2024 Sep;120(3):481-490. doi: 10.1016/j.ajcnut.2024.07.014. Epub 2024 Jul 16. Am J Clin Nutr. 2024. PMID: 39025328
-
S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population.Atherosclerosis. 2014 May;234(1):17-22. doi: 10.1016/j.atherosclerosis.2014.02.002. Epub 2014 Feb 18. Atherosclerosis. 2014. PMID: 24589563
-
Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism.Int J Biochem Cell Biol. 2015 Oct;67:158-66. doi: 10.1016/j.biocel.2015.06.015. Epub 2015 Jun 24. Int J Biochem Cell Biol. 2015. PMID: 26117455 Review.
Cited by
-
Dissecting Causal Relationship Among Immune Cells, Plasma Metabolites and Coronary Atherosclerosis: A Mendelian Randomization Study.Immunotargets Ther. 2025 Mar 6;14:175-188. doi: 10.2147/ITT.S508042. eCollection 2025. Immunotargets Ther. 2025. PMID: 40066076 Free PMC article.
-
Impacts of aging and fluid shear stress on vascular endothelial metabolism and atherosclerosis development.J Biomed Sci. 2025 Sep 1;32(1):83. doi: 10.1186/s12929-025-01177-z. J Biomed Sci. 2025. PMID: 40890841 Free PMC article. Review.
-
The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process.Biomolecules. 2024 Oct 31;14(11):1387. doi: 10.3390/biom14111387. Biomolecules. 2024. PMID: 39595564 Free PMC article. Review.
-
Sulfur-Element containing metabolic pathways in human health and crosstalk with the microbiome.Biochem Biophys Rep. 2023 Aug 13;35:101529. doi: 10.1016/j.bbrep.2023.101529. eCollection 2023 Sep. Biochem Biophys Rep. 2023. PMID: 37601447 Free PMC article. Review.
-
Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40-65: a prospective cross-sectional study.Cardiovasc Diabetol. 2023 Aug 24;22(1):219. doi: 10.1186/s12933-023-01942-0. Cardiovasc Diabetol. 2023. PMID: 37620823 Free PMC article.
References
-
- Aatola H, Koivistoinen T, Hutri-Kähönen N, Juonala M, Mikkilä V, Lehtimäki T, et al. . Lifetime fruit and vegetable consumption and arterial pulse wave velocity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation. (2010) 122:2521–8. 10.1161/CIRCULATIONAHA.110.969279 - DOI - PubMed
-
- Blaha MJ, Cainzos-Achirica M, Greenland P, McEvoy JW, Blankstein R, Budoff MJ, et al. . Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. (2016) 133:849–58. 10.1161/CIRCULATIONAHA.115.018524 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources